|
"lu yen shen"的相關文件
顯示項目 41-50 / 109 (共11頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Lin, Po-Han; Kuo, Wen-Hung; Huang, Ai-Chu; Lu, Yen-Shen; Lin, Ching-Hung; Kuo, Sung-Hsin; Wang, Ming-Yang; Liu, Chun-Yu; Cheng, Fiona Tsui-Fen; Yeh, Ming-Hsin; Li, Huei-Ying; Yang, Yu-Hsuan; Hsu, Yu-Hua; Fan, Sheng-Chih; Li, Long-Yuan; Yu, Sung-Liang; Chang, King-Jen; Chen, Pei-Lung; Ni, Yen-Hsuan; Huang, Chiun-Sheng; 郭文宏; 盧彥伸; 林璟宏; 倪衍玄; 郭頌鑫; 黃愛珠; 黃俊升; 林柏翰; 陳沛隆; 王明暘; 林季宏 |
| 國立臺灣大學 |
2015 |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Lin, Ching-Hung; Shen, Chen-Yang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; Yang, Chih-Hsin; Kuo, Wen-Hung; Chang, Dwan-Ying; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Chen, Chien-Jen; Lu, Yen-Shen; Cheng, Ann-Lii; 林志弘; 楊志新; 陳偉武; 郭文宏; 盧彥伸; 林璟宏; 陳怡君; 郭冠廷; 郭頌鑫; 吳佩芳; 鄭安理; 黃俊升; 張端瑩; 李日翔; 林季宏 |
| 國立臺灣大學 |
2015 |
Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer
|
Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 盧彥伸; 林璟宏; 連晃駿; 鄭安理; 黃俊升 |
| 國立臺灣大學 |
2015 |
Clinical significance of LKB1 protein and gene expression in breast cancer.
|
Chen, I. Chun; Chang, Yuan-Ching; Lu, Yen-Shen; Huang, Chiun-Sheng; Kuo, Wen-Hung; Wang, Ming-Yang; Kuo, Kuan-Ting; Wu, Pei-Fang; Hsueh, Tsu-Hsin; Lin, Ching-Hung; Cheng, Ann-Lii; 盧彥伸; 林璟宏; 郭冠廷; 吳佩芳; 鄭安理; 黃俊升; 王明暘 |
| 國立臺灣大學 |
2015 |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Lin, Ching-Hung; Chen, I-Chiun; Huang, Chiun-Sheng; Hu, Fu-Chang; Kuo, Wen-Hung; Kuo, Kuan-Ting; Wang, Chung-Chieh; Wu, Pei-Fang; Chang, Dwan-Ying; Wang, Ming-Yang; Chang, Chin-Hao; Chen, Wei-Wu; Lu, Yen-Shen; Cheng, Ann-Lii; 林志弘; 陳偉武; 郭文宏; 盧彥伸; 林璟宏; 陳怡君; 郭冠廷; 王中傑; 吳佩芳; 鄭安理; 黃俊升; 張端瑩; 王明暘; 張晉豪; 林季宏 |
| 國立臺灣大學 |
2015 |
BKM120 and BYL719 (PI3K inhibitors) sensitize estrogen receptor positive breast cancer cells to tamoxifen
|
Chen, I-Chun; Gao, Ming; Hsiao, Lii-Ping; Huang, Yi-Wen; Yu, Huei-Chieh; Yeh, Ling-Chiun; Cheng, Ann-Lii; Lu, Yen-Shen; 盧彥伸; 陳怡君; 鄭安理 |
| 國立臺灣大學 |
2015 |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu, Pei-Fang; Lin, Ching-Hung; Kuo, Ching-Hua; Chen, Wei-Wu; Yeh, Dah-Cherng; Liao, Hsiao-Wei; Huang, Shu-Min; Cheng, Ann-Lii; Lu, Yen-Shen; 陳偉武; 盧彥伸; 林璟宏; 郭錦樺; 吳佩芳; 鄭安理; 林季宏 |
| 國立臺灣大學 |
2015 |
Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
|
Lu, Yen-Shen; Chen, Tom Wei-Wu; Lin, Ching-Hung; Yeh, Dah-Cherng; Tseng, Ling-Ming; Wu, Pei-Fang; Rau, Kun-Ming; Chen, Bang-Bin; Chao, Ta-Chung; Huang, Shu-Min; Huang, Chiun-Sheng; Shih, Tiffany Ting-Fang; Cheng, Ann-Lii; 林志弘; 陳偉武; 盧彥伸; 林璟宏; 施庭芳; 吳佩芳; 鄭安理; 陳邦斌; 黃俊升; 林季宏 |
| 國立臺灣大學 |
2015 |
Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient
|
Wu, Li-An; Chang, Ruey-Feng; Huang, Chiun-Sheng; Lu, Yen-Shen; Chen, Hong-Hao; Chen, Jo-Yu; Chang, Yeun-Chung; 盧彥伸; 張允中; 陳若瑀; 黃俊升 |
| 國立臺灣大學 |
2014 |
Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance
|
Lien, Huang-Chun; Lee, Yi-Hsuan; Jeng, Yung-Ming; Lin, Ching-Hung; Lu, Yen-Shen; Yao, Yu-Tung; 盧彥伸; 鄭永銘; 林璟宏; 連晃駿; 李宜軒; 林季宏; 饒宇東 |
顯示項目 41-50 / 109 (共11頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
